Lipocortin I has been presumed to be synthesized and secreted in response to glucocorticoids yet the amino acid sequence of lipocortin I reveals no signal sequence typically necessary for proteins to enter the secretory pathway. The translocation of lipocortin I across membranes was analyzed in a cell-free system and in Xenopus oocytes. Based on the published sequence, the cDNA of human lipocortin I was cloned and expressed in Escherichia coli. Lipocortin I was purified and used to raise monoclonal antibodies. To test whether lipocortin I is secreted in vitro, transcribed lipocortin mRNA was translated in a wheat germ cell-free system in the absence and presence of microsomal membranes. Prolactin mRNA was used as a control for translocation of newly synthesized protein into membrane vesicles. Prolactin, but not lipocortin I, was translocated into the membranes. To test for secretion of lipocortin I in vivo, Xenopus oocytes were co-injected with transcripts encoding lipocortin I and prolactin, with and without the signal sequence. Prolactin with the signal sequence was released into the medium. However, neither prolactin without a signal sequence nor lipocortin I was released. Carbonate extraction, using an integral transmembrane protein as control, revealed no evidence for membrane integration of lipocortin I. Thus lipocortin I is not a secreted protein.
INTRODUCTION
Characterization of the biological properties of glucocorticoidinducible phospholipase A2 inhibitory proteins (lipocortins) has indicated that they (i) are synthesized and secreted in response to glucocorticoids, (ii) inhibit pancreatic phospholipase A2 in vitro, (iii) inhibit eicosanoid synthesis when added to cells, (iv) have anti-inflammatory activity in animal model systems of acute inflammation, and (v) are regulated by phosphorylation (Flower & Blackwell, 1979; Hirata, 1981; DiRosa et al., 1984; Flower, 1984; Bienkowski et al., 1989; Cirino et al., 1989) . The gene encoding a member of the lipocortin family, human lipocortin I, has been cloned and sequenced . Human lipocortin I expressed in Escherichia coli (r-lipocortin I) displays anti-phospholipase A2 activity in vitro , blocks the release of eicosanoids from guinea-pig perfused lung , inhibits the release of prostacyclin from human umbilical artery rings , mimics the inhibitory effect on superoxide generation by glucocorticoids in alveolar macrophages and diminishes carrageenin-induced oedema in the rat paw assay Cirino et al., 1989; MaridonneauParini et al., 1989) . Similar biological effects were also observed when non-recombinant lipocortin I was purified and applied extracellularly in various model systems Blackwell et al., 1983; Parente et al., 1984; Pepinsky et al., 1986; Fradin et al., 1988; Maridonneau-Parini et al., 1989) .
That extracellular addition of r-lipocortin I yields biological effects suggests the site of action of lipocortin I is extracellular and therefore lipocortin I must be secreted. This assumption concords with abrogation of dexamethasone-induced inhibition of prostanoid release from human embryonic skin fibroblasts or polymorphonuclear neutrophils and dexamethasone-induced inhibition of glycoconjugate secretion in tracheal organ cultures being reversed by addition to the culture medium of a monoclonal antibody against lipocortin (Errasfa et al., 1985; Fradin et al., 1988; Lundgren et al., 1988; Solito & Parente, 1989) . Further evidence for lipocortin I release comes from the findings that lipocortin I can be purified from cell-free peritoneal exudates of dexamethasone-stimulated rats Wallner et al., 1986) and from the partial purification and/or demonstration of lipocortin-like activity in the supernatants of glucocorticoid-stimulated lymphocytes, thymocytes, macrophages, fibroblasts, renal medullary or endometrial cells and in the perfusate of dexamethasone-treated lung preparations (Flower & Blackwell, 1979; Blackwell et al. 1980; Russo-Marie & Duval, 1982; Hirata & Iwata, 1983; Gupta et al., 1984; Errasfa et al., 1985; Gurpide et al., 1986) .
Recently, the mode of regulation and action of lipocortin I has been questioned. Evidence has been presented that first glucocorticoids do not induce lipocortin I (Broennegard et al., 1988; Bienkowski et al., 1989) and second, that lipocortin I does inhibit neither phospholipase A2 itself or the release of prostanoids (Davidson et al., 1987; Hullin et al., 1989; van Binsbergen et al., 1989) . Using translocation experiments across membranes in a cell-free system and in Xenopus oocytes, we demonstrate that lipocortin I is not secreted. Thus the conclusion that lipocortin I, the first clone isolated coding for a member of the lipocortin family, fulfils the operational definitions of a lipocortin, has to be revised. . Phage from plaques hybridizing with the probe were isolated and amplified. The lipocortin I cDNA insert was obtained by digesting A gtl 1 DNA with EcoRI. The lipocortin I cDNA insert was digested with Sau3A, subcloned into phage M 13 and characterized by sequencing the entire coding region using the dideoxy-chain-termination method (Sanger et al., 1977 mg/ml of calf liver tRNA, 0.5 mM-ATP, 0.5 mM-CTP, 0.5 mM-UTP, 0.1 mM-GTP, 0.5 mM-m7GpppG, 10 mM-dithiothreitol, 2 mM-spermidine, 6 mM-MgCl2, 40 mM-Tris/HCI, pH 7.5, and 8 units of RNasin. Reactions were carried out at 40°C for 1 h and aliquots of total reaction mix were used directly for injection or in vitro translation.
MATERIALS AND METHODS

Materials
Cell-free translation. Wheat germ extract was prepared according to Roman et al. (1976) . Aliquots (2 ul) of transcription reaction mix were added to translation reactions of 10 ,ul volume containing 20 % wheat-germ extract, 1 mCi [35S]methionine/ml, 0.2 mm each of the other 19 amino acids, 1 mM-ATP, 1 mM-GTP, 4 mM-phosphocreatine, 40 ug of creatine phosphokinase/ml, 100 4ug of calf liver tRNA/ml, 20 mM-Tris/HCl, pH 7.5, 2 mmMgCI2, 0.8 mM-spermidine, 140 mM-potassium acetate, 2 mMdithiothreitol and 8 units of RNasin. Reaction mixtures were incubated at 24°C for 1 h in the absence or presence of dog pancreas rough microsomes (Walter & Blobel, 1983) .
Post-translational proteinase protection. After incubation for 1 h at 24°C in the presence of dog pancreas membranes, translation mixtures were chilled on ice, adjusted to 10 mM-CaCl2, and divided into aliquots of 10 ,ul. Some were treated with proteinase K [dissolved in 10 mM-Tris/HCl (pH 8)/10 mM-CaCl2, and preincubated at 37°C for 30 min] at a final concentration of 0.2 mg/ml in either the presence or absence of 0.5 % Triton X-100. Proteinase K digestion was stopped by transferring the entire sample into 10 vols. of 0.1 M-Tris/HCl (pH 8.0)/i % SDS/2 mMphenylmethanesulphonyl fluoride (PMSF) in a boiling-water bath and incubating at 100°C for 10 min. Samples were diluted 20-fold in 1 % Triton X-100/0.I M-Tris/HCl (pH 8.0)/10 mm-EDTA/100 mM-NaCl, subjected to immunoprecipitation with monoclonal anti-lipocortin antibody (see below) or polyclonal anti-prolactin antibody (Rothman et al., 1988) and fractionated by SDS/PAGE. Fluorographed gels were subjected to autoradiography.
Microinjection of Xenopus oocytes. Xenopus oocytes were manually dissected and subsequently injected and labelled in modified Barth's saline solution (MBSH), containing
[35S]methionine, as described previously (Gurdon et al., 1971) .
MBSH contains 88 mM-NaCl, 1 mM-KCl, 2.4 mM-NaHCO3, 0.82 mM-MgSO4, 0.33 mM-Ca(NO3)2, 0.41 mM-CaCl2, 10 mM-Hepes, pH 7.6. Inmunoprecipitation of oocyte translation products. Medium and oocytes were separated. To 100 ,u of medium, 50 ,u of 1 % SDS/0.1 M-Tris/HCl (pH 8.0)/2 mM-PMSF was added and the mixture, boiled for 5 min; oocytes were homogenized in 20 ,ul of 10% SDS/0.I M-Tris/HCl (pH 8.0)/2 mM-PMSF/oocyte and boiled for 5 min. Medium and oocyte homogenates were adjusted to 1 ml with buffer A [10% Triton X-100/0.1 M-Tris/HCl (pH 8.0)/0.1 M-NaCl/0.01 M-EDTA/2 mM-PMSF] and incubated for at least 12-16 h at 4°C in order to release proteins. After incubation, samples were centrifuged in an Eppendorf centrifuge at 10000 rev./min for 5 min to remove aggregates. The supernatants were transferred to fresh tubes. Purified monoclonal anti-lipocortin antibody or polyclonal anti-prolactin antibody (control) was added stepwise to each tube. The mixtures were incubated for 8-12 h at 4 'C, 15 ,u of a 50 % slurry of anti-mouse IgG coupled to Sepharose 4B (for lipocortin precipitation) or Protein A-Sepharose 4 CL4B (for prolactin precipitation) in buffer A added, and incubation continued overnight at 4 'C using a rotator. The Sepharose samples were washed three times with buffer A and subsequently twice with buffer containing 0.1 M-Tris/HCI, pH 7.5, 0.1 M-NaCl and 2 mM-PMSF to remove residual Triton X-100.
Carbonate extraction (Fujiki et al., 1982) . A crude vesicle preparation was obtained from oocytes micro-injected with [35S]methionine and transcripts encoding lipocortin, bovine preprolactin and a chimaeric transmembrane protein composed of the signal sequence of E. coli fl-lactamase (SL) fused sequentially to 109 amino acids of chimpanzee a-globin containing a glycosylation site (gG), the stop transfer sequence (ST) of mouse IgM heavy chain and 150 residues of bovine prolactin (P) (Simon et al., 1987; Rothman et al., 1988) . The chimaeric protein was named PSPSL * gG ST* P (Rothman et al., 1988) .
[35S]methionine and the three transcripts were micro-injected simultaneously (1.2:0.2:0.6, v/v). The oocytes were homogenized (20 ,u/oocyte) at 4°C in an iso-osmotic buffer containing 10 % (w/v) sucrose, 150 mM-NaCI, 10 mM-magnesium acetate and 20 mM-Tris/ HCl, pH 7.6. A crude vesicle preparation was obtained by using a ground-glass homogenizer. Each sample was divided into two aliquots. One aliquot was treated with 5 ml of 0.1 M-Na2CO3, pH 11.5, the other with 0.25 M-sucrose/0.1 M-Tris/HCl (pH 7.5), and both were incubated for 30 min on ice. The extracted samples were then centrifuged for 1 h at 55000 rev./min in an ultracentrifuge (Rotor Ti7O.1, Beckman). The supernatants were removed, neutralized with acetic acid, 50,ug of lysozyme added as carrier and the mixture precipitated with a final concn. of 15 % trichloroacetic acid. Trichloroacetic acid precipitates were spun down and washed with diethyl ether/ethanol (1:1, v/v). Both precipitates and original pellets were dissolved in 100 ,ul of 0.1 MTris/HCI (pH 8.9)/I % SDS and incubated at 37°C for 30 min and at 100°C for 2 min. Samples were then diluted with buffer A for immunoprecipitation.
Expression of lipocortin in E. coli HB101. The pET-3cLip plasmid and the control plasmid contained the entire coding sequence of lipocortin I either in correct or reverse orientation, the phage T7 promoter, the phage T7 gene 10 translation start and transcription terminator site (Rosenberg et al., 1987) . This vector directs the production of large amounts of proteins in E. coli HB1I1 after infection by CE6, a phage A derivative that carries the gene for T7 RNA polymerase (Studier & Moffatt, 1986) . Transformed E. coli HB1I1 cultures were grown in the presence of ampicillin (20 ,ug/ml) and 0.2 % maltose at 37°C in a shaking water bath (Schwartz, 1967) . When the A600 reached a value of 0.6-1.0, MgSO4 was added to a final concentration of 10 mm and purified CE6 phage to a final concentration of 1 x 109/ml. Cells were harvested 3 h after infection. The bacteria were centrifuged at 1000 g for 5 min, suspended in SDS/PAGE loading buffer (Maniatis et al., 1982) , boiled for 10 min and loaded on to a 12.5 % polyacrylamide gel. Gels were stained with Coomassie Blue or silver.
Monoclonal antibodies. Human lipocortin I was prepared for transformed E. coli HB1I1. The bacteria were centrifuged, suspended in 150 mM-KCI/2 mM-MgCl2/20 mM-Hepes, pH 7.4, and passed twice through a Yeda press operated at a nitrogen pressure of 505 kPa. Immediately CaCI2 was added to the lysate to a final concentration of I mm. The mixture was kept on ice for 30 min, and centrifuged for 15 min at 7200 g at 4 'C. The sediment was washed twice with 150 mM-KCI/2 mM-MgCl/ 20 mM-Hepes, pH 7.4, containing 1 mM-CaCl2. The sediment was re-suspended in the same buffer containing 2 mM-EGTA instead of CaCl2 in order to abrogate the Ca2+-dependent binding of lipocortin I to phospholipids (Glenney & Zokas, 1988 Lipocortin I (100,ag), emulsified with 1 vol. of complete Freund's adjuvant, was injected into the peritoneal cavity of 6-week-old BALB/cJ mice. Mice were boosted twice with 100 ,ug of lipocortin I in incomplete Freund's adjuvant and killed 4 days after the last booster injection. The spleen was excised and somatic-cell fusion was performed by the method initially described by Koehler & Milstein (1975) using PAI myeloma cells (Stocker et al., 1982 . The lipocortin I cDNA was cloned downstream of the phage T7 promoter in the vector pET (Rosenberg et al., 1987) and expressed in E. coli using CE6 phages for delivery of the gene encoding T7 polymerase (Fig. 1) . The appearance of a strong band of the expected molecular mass (38.7 kDa) in lane 3 (plasmid carrying cDNA insert in the correct orientation), but not in lanes 5 and 6 (plasmid carrying cDNA insert in reverse orientation), shows that human lipocortin I is indeed produced. As suggested by Studier & Moffatt (1986) , optimal protein synthesis was obtained after infection with 1.0 x 10 phages/ml (Fig. 1, lane 3) . Glenney & Zokas (1988) showed that calpactin II (which is identical with lipocortin I) extracted from tissue associates with phospholipids in the presence of Ca2. Since recombinant lipocortin I is expected to exhibit the same physico-chemical properties, bacterial lysates were precipitated in the presence of Ca2+, and Ca2+-binding proteins were re-solubilized by addition of EGTA. Lipocortin I was found in the supernatant (Fig. 2, lane  1) and in the sediment (Fig. 2, lane 2) of bacterial lysates. By washing the sediment sequentially with buffer containing 1 mmCaCl2, non-Ca2+-dependent binding proteins were removed. Upon re-solubilization of the sediment with EDTA, a strong band of lipocortin I was detected (Fig. 2, lane 3) , indicating that the purification procedure used by Glenney & Zokas (1988) secreted proteins which do not have a signal sequence (Price et al., 1987; Silve et al., 1987; Pfaffle et al., 1988 (PT) an N-terminal signal sequence in Xenopus oocytes during the first 48 h after injection of transcripts. Lanes: 1, unprocessed 'in vitro' translation product from the wheat-germ system; 2-5, analysis of medium; 6, analysis of oocytes.
system from wheat-germ in the presence of dog pancreas membranes. Therefore lipocortin I cDNA was transcribed from linearized pSP64TLip using SP6 polymerase. The resulting mRNA was translated in a wheat-germ cell-free system in the absence or presence of microsomal membranes prepared from dog pancreas (Fig. 3a, lanes 1 and 2) . It has previously been shown that proteins translocated across microsomal membranes are protected from proteinase K and that the protection is abrogated following solubilization of the lipid bilayer with the non-ionic detergent Triton X-100 (Rothman et al., 1988) . As shown in Fig. 3(a) (lanes 3 and 4) lipocortin I was not protected from proteinase K, indicating that it was not translocated into microsomes, and hence is unlikely to follow the conventional secretory pathway. In the same experiment, prolactin was used as Vol. 275 protein PSPSL * gG -ST -P (39 kDa) and prolactin (30 kDa) Homogenates from 10 oocytes were prepared and exposed to Na2CO3 (lanes 2, 3, 6, 7) or sucrose (lanes 4, 5, 8 and 9), then separated into supernatant (S) and pellet (P) fractions by centrifugation. Each fraction was precipitated with anti-lipocortin or anti-prolactin antibody. The precipitated products were revealed by SDS/PAGE and autoradiography. Lanes: 1, lipocortin I mRNA translated in the cell-free system and used as a marker; 2 and 3, pellet and supernatant following carbonate extraction of lipocortin; 4 and 5, pellet and supernatant following sucrose extraction of lipocortin; 6 and 7, pellet and supernatant following carbonate extraction of pSPSL-gG. ST.P and prolactin; 8 and 9, pellet and supernatant following sucrose extraction of pSPSL -gG -ST P and prolactin. a control in order to demonstrate that secreted proteins are translocated into microsomal membranes (Fig. 3b, lane 3) and that this translocated protein is protected from proteinase K (Fig. 3b, lane 4 (Fig. 4a,  lanes 3 , 5, 7, 9) . No lipocortin I was found in the culture medium (Fig. 4a, lanes 11, 13, 15, 17 ). Oocytes injected with control solution did not express lipocortin I (Fig. 4b, lanes 2, 4, 6, 8) . In order to demonstrate unambiguously that the oocytes were able to handle proteins according to the presence or absence of the signal sequence, Xenopus oocytes were co-injected with transcripts encoding lipocortin I, prolactin with an N-terminal signal sequence (BPI) and a prolactin fragment (amino acids 57-199) lacking a signal sequence (PT) (which are expressed as a cytoplasmic protein) (Simon et al., 1987) . Again these oocytes did not release either lipocortin I (results similar to Fig. 4a) or PT (Fig. 4c, lanes 2-5) into the medium, but did secrete authentic prolactin (Fig. 4c, lanes 2-5) .
It is conceivable that lipocortin I, while not secreted, is integrated into membranes of Xenopus oocytes. Carbonate extraction was used to investigate this possibility (Fujiki et al., 1982) . With this procedure, vesicles of oocytes are converted into sheets and protein-protein interactions disrupted by denaturation, whereas protein-lipid interactions are retained. By that method, lipocortin I was extracted (Fig. 5, lane 2) , whereas the transmembrane protein PSPSL gG * ST *P remained unextracted from the pellet (Fig. 5, lane 6) . As a control, the same procedure was performed with sucrose instead of carbonate (Fig. 5, lanes 4, 5, 8, 9 ). Sucrose does not disrupt vesicles and protein-proteiin interactions (Fig. 5, lanes 8 and 9) . Thus a stable insertion of lipocortin I into the bilayer of oocytes can be excluded on this basis.
The analysis of the expression of a protein in the wheat-germ cell-free system allows investigations of translocation processes which are of predictive value for a protein in intact cells (Katz & Lodish, 1979; Lingappa, 1989) . For lipocortin I, the absence of translocation into pancreas membranes is in agreement with the absence of secretion of that protein by oocytes. Xenopus oocytes translate injected mRNA with great efficiency, process the resulting proteins and distribute them into the correct compartment (David & Sargent, 1988 Glenney (1987) on the basis of cell-fractionation studies using human fibroblasts. The reason why in many (Flower & Blackwell, 1979; Blackwell et al., 1980; Russo-Marie & Duval, 1982; Hirata & Iwata, 1983; Gupta et al., 1984; Errasfa et al., 1985; Gurpide et al., 1986; Wallner et al., 1986; Lundgren et al., 1988; Solito & Parente, 1989) , but not in all (Bienkowski et al., 1989) , of the previous investigations, lipocortin was has previously been suggested, the present results clearly indicate that lipocortin I is not secreted. Thus the conclusion that lipocortin I, the first clone isolated coding for a member of the lipocortin family, fulfils the operational definitions ofa lipocortin, has to be revised.
